CHICAGO — It’s been a rocky month for cannabidiol (CBD) brands. In late November, the U.S. Food and Drug Administration (FDA) issued warning letters to 15 companies for illegally selling CBD products in ways that violate the Federal Food, Drug and Cosmetic Act (FD&C Act).
According to the warning letters, the companies were marketing CBD products as remedies that treat diseases and for other therapeutic uses in humans and animals. Some have also marketed CBD products as dietary supplements and are adding CBD to human and animal foods, while others have marketed the products for infants and children.
- Click here to download CSP's 2020 CBD Category Digest, created in partnership with Floyd's of Leadville.
Here’s a compilation of the latest news stories relating to the budding product ingredient …
Four retailers offered their insights and perspectives at CSP’s CBD & Convenience Retail forum
Brand under fire for marketing product as dietary supplement
Answering the question ‘Will my CBD get past the Transportation Security Administration (TSA)?’
'Analytic relationship' with Charlotte’s Web intended to better guide the U.S. retail market
Permits states to submit plans for regulating hemp production in their region
Are food and beverages an effective way of getting CBD into your system?
Things to be taken into consideration before deciding on your CBD quantity